Insider Trading April 13, 2026 04:13 PM

Rockwell CTO Disposes $78,209 in Shares as Analysts Grapple with Valuation

Cyril Perducat's April transactions coincide with mixed analyst views and guidance that sits below the company's long-term growth target

By Maya Rios ROK
Rockwell CTO Disposes $78,209 in Shares as Analysts Grapple with Valuation
ROK

Cyril Perducat, Rockwell Automation's senior vice president and chief technology officer, sold 198 shares on April 10, 2026, for roughly $78,209. The sale occurred amid a 75% year-over-year stock rise and analyst commentary highlighting valuation concerns and mixed ratings. The company also reported option exercises by Perducat on April 9 of 581 shares at a zero exercise price.

Key Points

  • Rockwell CTO Cyril Perducat sold 198 shares on April 10, 2026, at a weighted average price of $394.9963 for a total of $78,209; sale prices ranged from $394.9950 to $395.00.
  • Perducat also exercised options for 581 shares on April 9, 2026, at a $0 exercise price, with those shares reported as having a total value of $0.
  • The stock has risen roughly 75% over the past year and trades at $407.64 per InvestingPro data, though InvestingPro flags a P/E of 46.22 as indicating possible overvaluation; analysts' views on Rockwell are mixed.

Cyril Perducat, who serves as senior vice president and chief technology officer at Rockwell Automation (NASDAQ: ROK), completed a sale of 198 shares of the company's common stock on April 10, 2026. The transaction carried a weighted average sale price of $394.9963 per share, producing a total consideration of $78,209. Reported sale prices for the lot ranged between $394.9950 and $395.00.

The insider sale followed an option exercise on April 9 in which Perducat acquired 581 shares of Rockwell Automation common stock at an exercise price of $0, with those shares reported as having a total value of $0.

Market context accompanying the filings shows Rockwell shares have climbed about 75% over the past year, with the stock cited as trading at $407.64 in InvestingPro data referenced in the disclosures. InvestingPro analysis included in the same briefing indicates the shares appear expensive at current levels, with a price-to-earnings multiple of 46.22.

Alongside the insider transactions and valuation commentary, the company's own guidance and external analyst views have been mixed. Rockwell is guiding to 4% organic growth at the midpoint for fiscal 2026, while reiterating an ambition to finish within its longer-term organic growth framework of 5% to 8%.

Several sell- and buy-side firms are also on the record with differing stances. Jefferies moved Rockwell from Buy to Hold and lowered its price target to $380 from $490, explicitly citing valuation concerns. Conversely, Argus maintained a Buy rating with a $465 price target, interpreting recent stock weakness as an opportunity to accumulate shares. Barclays commented that Rockwell, together with Emerson Electric, is relatively insulated from potential AI-driven disruption because of robust software capabilities. Meanwhile, Morgan Stanley analysts highlighted the potential upside for U.S. industrial firms, including Rockwell, tied to reshoring trends.

These developments - the insider sale, option exercises, company guidance, and varied analyst opinions - appear amid broader market and macro uncertainties referenced by the firms' commentary. For investors seeking deeper proprietary analysis, the reporting notes availability of a comprehensive Pro Research Report on ROK, one of more than 1,400 reports referenced in the InvestingPro offering.


Disclosure: This report notes InvestingPro data and research availability. Additional legal or editorial disclosures are provided separately.

Risks

  • Valuation risk - InvestingPro analysis notes a P/E of 46.22, suggesting the stock could be overvalued at current trading levels; this impacts equity investors in the industrials and automation sectors.
  • Analyst and market uncertainty - Mixed ratings and revised price targets from Jefferies, Argus, Barclays, and Morgan Stanley reflect differing views that introduce investor uncertainty for industrial and software-exposed firms.
  • Growth execution risk - Rockwell's fiscal 2026 midpoint guidance of 4% organic growth is below its long-term 5% to 8% framework, creating potential execution risk if the company does not return to its target range; this is relevant to industrial manufacturing and automation markets.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026